Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
BMC Microbiol ; 24(1): 344, 2024 Sep 14.
Article in English | MEDLINE | ID: mdl-39271999

ABSTRACT

BACKGROUND: In the present study, we aimed to determine the frequency of the csgA, fimH, mrkD, foc, papaGI, papGII and papGIII genes, to provide and to design fimbrial adhesin gene (FAG) patterns and profiles for the isolated uropathogenic Escherichia coli (UPEC) strains. METHODS: The enrollment of 108 positive urine samples was performed during seven months, between January 2022 and July 2022. The UPEC strains were confirmed through the standard microbiological and biochemical tests. The antimicrobial susceptibility test was performed through the Kirby-Bauer disc diffusion method. Molecular screening of FAGs was done through the polymerase chain reaction technology. The statistical analyses including chi square and Fisher's exact tests were performed to interpret the obtained results in the present study. RESULTS: As the main results, the antimicrobial resistance (AMR) patterns, multi- (MDR) and extensively drug-resistance (XDR) patterns and FAG patterns were designed and provided. fimH (93.3%), csgA (90.4%) and papG (37.5%) (papGII (30.8%)) genes were recognized as the top three FAGs, respectively. Moreover, the frequency of csgA-fimH gene profile was identified as the top FAG pattern (46.2%) among the others. The isolates bearing csgA-fimH gene profile were armed with a versatile of phenotypic AMR patterns. In the current study, 27.8%, 69.4% and 1.9% of the UPEC isolates were detected as extended-spectrum ß-lactamases (ESBLs) producers, MDR and XDR strains, respectively. CONCLUSIONS: In conclusion, detection, providing and designing of patterns and profiles in association with FAGs, AMR feature in UPEC strains give us an effective option to have a successful and influential prevention for both of UTIs initiation and AMR feature.


Subject(s)
Escherichia coli Infections , Escherichia coli Proteins , Fimbriae Proteins , Fimbriae, Bacterial , Urinary Tract Infections , Uropathogenic Escherichia coli , Uropathogenic Escherichia coli/genetics , Uropathogenic Escherichia coli/drug effects , Humans , Escherichia coli Proteins/genetics , Escherichia coli Infections/microbiology , Urinary Tract Infections/microbiology , Fimbriae Proteins/genetics , Fimbriae Proteins/metabolism , Fimbriae, Bacterial/genetics , Fimbriae, Bacterial/metabolism , Anti-Bacterial Agents/pharmacology , Microbial Sensitivity Tests , Adhesins, Escherichia coli/genetics , Adhesins, Escherichia coli/metabolism , Female , Adult , Molecular Chaperones/genetics , Molecular Chaperones/metabolism , Male , Drug Resistance, Multiple, Bacterial/genetics , Middle Aged , Young Adult , Adolescent , Bacterial Proteins
SELECTION OF CITATIONS
SEARCH DETAIL